Pharmaceuticals

Fighting Diseases

Latest News
June 30, 2022
Not intended for U.S. and UK Media
Kerendia™ (finerenone) approved in China for the treatment of adults with chronic kidney disease associated with type 2 diabetes
June 29, 2022
Not intended for U.S. and UK Media
Bayer opens new Research & Innovation Center in Boston-Cambridge demonstrating its commitment to precision oncology
June 28, 2022
Not intended for U.S. and UK Media
Bayer expands Radiology Business into AI Market with Calantic™ Digital Solutions